These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 12684587

  • 21. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.
    Banerjee S, Bishop WP.
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):324-30. PubMed ID: 16954954
    [Abstract] [Full Text] [Related]

  • 22. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
    Kiszka-Kanowitz M, Theede K, Nielsen AM.
    Ugeskr Laeger; 2015 Jun 22; 177(26):1253-5. PubMed ID: 26550625
    [Abstract] [Full Text] [Related]

  • 23. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
    Winter JW, Gaffney D, Shapiro D, Spooner RJ, Marinaki AM, Sanderson JD, Mills PR.
    Aliment Pharmacol Ther; 2007 May 01; 25(9):1069-77. PubMed ID: 17439508
    [Abstract] [Full Text] [Related]

  • 24. Review article: thiopurines in inflammatory bowel disease.
    Derijks LJ, Gilissen LP, Hooymans PM, Hommes DW.
    Aliment Pharmacol Ther; 2006 Sep 01; 24(5):715-29. PubMed ID: 16918876
    [Abstract] [Full Text] [Related]

  • 25. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
    Sparrow MP, Hande SA, Friedman S, Cao D, Hanauer SB.
    Clin Gastroenterol Hepatol; 2007 Feb 01; 5(2):209-14. PubMed ID: 17296529
    [Abstract] [Full Text] [Related]

  • 26. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L, Van Dieren JM, Van Deventer HJ, Stokkers PC, Van der Woude JC, Van Vuuren AJ, Benninga MA, Escher JC, Hommes DW.
    Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1137-41. PubMed ID: 16611274
    [Abstract] [Full Text] [Related]

  • 27. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Dubinsky MC, Reyes E, Ofman J, Chiou CF, Wade S, Sandborn WJ.
    Am J Gastroenterol; 2005 Oct 15; 100(10):2239-47. PubMed ID: 16181376
    [Abstract] [Full Text] [Related]

  • 28. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
    Dubinsky MC, Feldman EJ, Abreu MT, Targan SR, Vasiliauskas EA.
    Am J Gastroenterol; 2003 May 15; 98(5):1058-63. PubMed ID: 12809828
    [Abstract] [Full Text] [Related]

  • 29. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
    Gilissen LP, Wong DR, Engels LG, Bierau J, Bakker JA, Paulussen AD, Romberg-Camps MJ, Stronkhorst A, Bus P, Bos LP, Hooymans PM, Stockbrügger RW, Neef C, Masclee AA.
    J Crohns Colitis; 2012 Jul 15; 6(6):698-707. PubMed ID: 22398098
    [Abstract] [Full Text] [Related]

  • 30. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M.
    Ther Drug Monit; 2007 Feb 15; 29(1):1-5. PubMed ID: 17304143
    [Abstract] [Full Text] [Related]

  • 31. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.
    Ansari A, Arenas M, Greenfield SM, Morris D, Lindsay J, Gilshenan K, Smith M, Lewis C, Marinaki A, Duley J, Sanderson J.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):973-83. PubMed ID: 18616518
    [Abstract] [Full Text] [Related]

  • 32. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
    Schwab M, Herrlinger K, Schaeffeler E, Stange EF.
    Dtsch Med Wochenschr; 2003 Feb 21; 128(8):378-85. PubMed ID: 12594624
    [No Abstract] [Full Text] [Related]

  • 33. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
    Heneghan MA, Allan ML, Bornstein JD, Muir AJ, Tendler DA.
    J Hepatol; 2006 Oct 21; 45(4):584-91. PubMed ID: 16876902
    [Abstract] [Full Text] [Related]

  • 34. The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.
    Kim DU, Kim YH, Kim BJ, Chang DK, Son HJ, Rhee PL, Kim JJ, Rhee JC.
    Hepatogastroenterology; 2009 Oct 21; 56(94-95):1395-402. PubMed ID: 19950798
    [Abstract] [Full Text] [Related]

  • 35. [Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease].
    Gisbert JP, González-Lama Y, Maté J.
    Gastroenterol Hepatol; 2006 Nov 21; 29(9):568-83. PubMed ID: 17129552
    [Abstract] [Full Text] [Related]

  • 36. Bioequivalence of azathioprine products.
    Baker DE.
    Rev Gastroenterol Disord; 2003 Nov 21; 3(4):219-23. PubMed ID: 14668694
    [Abstract] [Full Text] [Related]

  • 37. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF.
    Rev Gastroenterol Disord; 2003 Nov 21; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [Abstract] [Full Text] [Related]

  • 38. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
    Hlavaty T, Batovsky M, Balakova D, Pav I, Celec P, Gregus M, Zakuciova M, Hlista M, Horakova M, Desatova B, Koller T, Toth J, Kadasi L, Huorka M, Slovak IBD study group (SK IBD).
    Bratisl Lek Listy; 2013 Nov 21; 114(4):199-205. PubMed ID: 23514552
    [Abstract] [Full Text] [Related]

  • 39. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
    Gardiner SJ, Gearry RB, Begg EJ, Zhang M, Barclay ML.
    Clin Gastroenterol Hepatol; 2008 Jun 21; 6(6):654-60; quiz 604. PubMed ID: 18467186
    [Abstract] [Full Text] [Related]

  • 40. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
    Aranda R, Horgan K.
    Semin Gastrointest Dis; 1998 Jan 21; 9(1):2-9. PubMed ID: 9547850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.